BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2003
View Archived Issues
Three series of COX-2 inhibitors prepared and tested at GSK
Read More
Protection of heart allografts by alpha-MSH in rats
Read More
Potential use of early kidney precursors in renal transplantation
Read More
Sex differences for NO-induced effects in sickle cell disease
Read More
Hemoglobin raffimer in coronary artery bypass graft surgery
Read More
Lipid-lowering effects reported for a diet combining soy proteins, plant sterols and viscous fiber
Read More
New antitumor agents prepared and tested by French team
Read More
Boehringer Ingelheim claims new telomerase inhibitors
Read More
Wyeth presents new beta-lactamase inhibitors in recent patent
Read More
Orally available carbapenem antibiotics in early development at Kyoto Pharmaceutical
Read More
Banyu scientists prepare and test piperidine-based NPY antagonists
Read More
New series of antibacterial compounds discovered by Washington U. scientists
Read More
CAT and Dyax expand licensing agreement
Read More
ABI-007 receives fast track status for metastatic breast cancer
Read More
Galenica and Spanish National Center of Biotechnology to develop smallpox subunit vaccine
Read More
Novartis and Ivax sign Airmax inhaler agreement for respiratory products
Read More
Novartis seeks approval for lower dose of Estalis in Sweden
Read More
Ono and GSK sign agreement for Ono-4128
Read More
Zavesca marketing approval sought in Israel
Read More
Ranexa terminates ventricular tachycardia in preclinical study
Read More
Positive phase III results for Enbrel in psoriasis
Read More
New title added to the Drug R&D Backgrounders topic list - Bipolar Disorder
Read More
Vascular targeting agent ZD-6126 exerts significant antitumor activity at well-tolerated doses
Read More
Chiesi's budesonide Modulite pMDI approved in Germany
Read More
Biprel launched in Canada for hypertension
Read More